ExploreInterventionHistory of gastrostomy tube placement
Intervention

History of gastrostomy tube placement

Also known as: Gastrostomy tube placement History of gastrostomy tube placement History of placement of gastrostomy tube History of placement of gastrostomy tube (situation)
21 findings 1 paper 10 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (50)

None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.

Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28

Size: OR 4.06 CI: 95% CI 3.12-5.28
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10

Papers (1)